Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
 
Register | Sign in
Home Page>Products
  Product News
EpiCypher™ Announces Next-Generation Histone Peptide Array
Friday, September 05, 2014
EpiTitan™ to replace first-generation EpiGold™ array.

RC900 Rotary Evaporator Wins Prestigious Red Dot Award
Thursday, September 04, 2014
An efficient, robust instrument set to transform rotary evaporation.

Agilent Introduces Higher-Performance Q-TOF GC/MS System
Thursday, September 04, 2014
Company introduces 7200B system, featuring optimized hardware/software capabilities.

Maintain Water Health with Reliable Chlorophyll Measurement from Jenway
Thursday, September 04, 2014
Efficient, reliable chlorophyll measurement from Jenway 67 series spectrophotometers.

Malvern & Aurora Water Present on Potential of On-line Zeta Potential in Water Treatment
Thursday, September 04, 2014
Both Companies will present new research at the 2014 RMSAWWA/RMWEA Joint Annual Conference, Albuquerque, New Mexico, USA.

PerkinElmer Launches Innovative Multiplexing System
Thursday, September 04, 2014
AlphaPlex™ reagent technology provides life sciences researchers with more data in less time.

Selvita Licenses Cresset’s Forge and Spark
Thursday, September 04, 2014
Computational tools for SAR analysis and ligand-based design.

Major Pharma Chooses CompacT SelecT Automated Cell Culture System
Thursday, September 04, 2014
To generate consistent, high quality cell plates for transport assays.

FEI Releases New Helios NanoLab G3 DualBeam
Thursday, September 04, 2014
Next generation DualBeam extends Helios performance leadership while enhancing usability with a new user interface and workflow-specific configurations.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 10504
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv